Glen O'Sullivan, MD
Orthopedic Surgery · Yreka, CANPI 1972504652
Payments from drug & device makers
What this record shows
Medtronic accounts for 82.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $2,307 and has fallen 85.4% since, to $337 in 2025.
Across 26 payments — averaging $107.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Saluda Medical Americas, Inc.$267
- Avanos Medical$117
- Vertos Medical, Inc.$62
- Boston Scientific$41
- Vertex$18
What the payments were for
- Travel & lodging$1,53855%
- Food & beverage$1,26345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 16 | $2,296 |
| Saluda Medical Americas, Inc. | 3 | $267 |
| Avanos Medical | 2 | $117 |
| Vertos Medical, Inc. | 1 | $62 |
| Boston Scientific | 3 | $41 |
| Vertex | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,801 in reported general payments places this provider in the 75th percentile of 130 orthopedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 328 | $10,655 |
| Gabapentin | 338 | $2,649 |
| Pregabalin | 87 | $1,680 |
| Oxycodone Hcl | 176 | $1,612 |
| Methylprednisolone | 157 | $1,021 |
| Cyclobenzaprine Hcl | 184 | $1,011 |
| Meloxicam | 212 | $818 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $809 |
| Ibuprofen | 54 | $612 |
| Methocarbamol | 35 | $611 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $525 |
| Diclofenac Sodium | 14 | $389 |
| Nabumetone | 18 | $218 |
| Cephalexin | 22 | $191 |
| Naproxen | 11 | $108 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Yreka
- Marshall ChingOroville$17.8M
- Ran SchwarzkopfOrange$2M
- Brian ChingOroville$1.4M
- Peter KurzweilLong Beach$494K
- Scott Hackerla Mesa$434K
- Richard NussbaumSherman Oaks$238K
- William KimTorrance$164K
- Peter BordenTorrance$111K
- Raymond FolmarIrvine$70K
- Phillip YuanLong Beach$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.